DISEASE INDICATIONS: Rheumatoid Arthritis

MANUFACTURER: Eli Lilly Nederland B.V.

USAGE: Oral

MEDICINE APPROVED BY: European Medical Agency (EMA)

Olumiant (baricitinib) is a medication used to treat adults with rheumatoid arthritis. It is a JAK inhibitor, which inhibits the production of inflammatory substances. The RA-BEAM clinical trial showed significant improvements in patients who received Olumiant compared to placebo.